SynthesisBreast cancer research and treatment2026
Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis.
Imad Barjij et al.PubMed ↗Publisher ↗
No numbers read from the abstract.